Plasma transfusion: History, current realities, and novel improvements

Shock

Volumn 46, Issue 5, 2016, Pages 468-479

  Watson, Justin J J ^a   Pati, Shibani ^b   Schreiber, Martin A ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Coagulopathy; Hemorrhage; Lyophilized plasma; Novel reconstitution; Plasma; Resuscitation; Transfusion; Trauma

Indexed keywords

ASCORBIC ACID; BLOOD CLOTTING FACTOR; FRESH FROZEN PLASMA; PROTEIN S; STERILE WATER;

AFGHANISTAN; BLEEDING; BLOOD BANK; BLOOD CLOTTING DISORDER; BLOOD STORAGE; FLUID RESUSCITATION; HEMORRHAGIC SHOCK; HUMAN; INJURY; IRAQ; PLASMA TRANSFUSION; REVIEW; VIET NAM; WAR; BLOOD COMPONENT THERAPY; BLOOD TRANSFUSION; HISTORY; INFLAMMATION; PLASMA; PROCEDURES; TRENDS;

BLOOD COMPONENT TRANSFUSION; BLOOD TRANSFUSION; HISTORY, 20TH CENTURY; HUMANS; INFLAMMATION; PLASMA; SHOCK, HEMORRHAGIC;

EID: 84977160704     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0000000000000663     Document Type: Review

References (136)

1. Burman S, Cotton B: Trauma patients at risk for massive transfusion: the role of scoring systems and the impact of early identification on patient outcomes. Expert Rev Hematol 2:211-218, 2012.
2. Sauaia A, Moore FA, Moore EE, Moser KS, Brennan R, Read RA, Pons PT: Epidemiology of trauma deaths: a reassessment. J Trauma 38(2):185-193, 1995.
3. Holcomb JB, del Junco DJ, Fox EE, Wade CE, Cohen MJ, Schreiber MA, Alarcon LH, Bai Y, Brasel KJ, Bulger EM, et al.: The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study: comparative effectiveness of a time-varying treatment with competing risks. JAMA Surg 148(2):127-136, 2013.
4. Hoyt D: A clinical review of bleeding dilemmas in trauma. Semin Hematol 41(1 suppl 1):40-43, 2004.
5. Cohen MJ: Towards hemostatic resuscitation: the changing understanding of acute traumatic biology, massive bleeding, and damage-control resuscitation. Surg Clin North Am 92(4):877-891, 2012.
6. Schreiber MA: Coagulopathy in the trauma patient. Curr Opin Crit Care 11(6):590-597, 2005.
7. Maegele M, Lefering R, Yucel N, Tjardes T, Rixen D, Paffrath T, Simanski C, Neugebauer E, Bouillon B: AG Polytrauma of the German Trauma Society (DGU): Early coagulopathy in multiple injury: an analysis from the German trauma registry on 8724 patients. Injury 38(3):298-304, 2007.
8. Maegele M, Spinella PC, Schochl H: The acute coagulopathy of trauma: mechanisms and tools for risk stratification. Shock 38(5):450-458, 2012.
9. Maegele M, Schochl H, Cohen MJ: An up-date on the coagulopathy of trauma. Shock 41(suppl 1):S21-S25, 2014.
10. Frith D, Davenport R, Brohi K: Acute traumatic coagulopathy. Curr Opin Anaesthesiol 25(2):229-234, 2012.
11. Brohi K, Cohen MJ, Davenport RA: Acute coagulopathy of trauma: mechanism, identification and effect. Curr Opin Crit Care 13(6):680-685, 2007.
12. Pidcoke HF, Aden JK, Mora AG, Borgman MA, Spinella PC, Dubick MA, Blackbourne LH, Cap AP: Ten-year analysis of transfusion in operation Iraqi freedom and operation enduring freedom: increased plasma and platelet use correlates with improved survival. J Trauma Acute Care Surg 73(6 suppl 5):S445-S452, 2012.
13. Hess J, Lawson J: The coagulopathy of trauma versus disseminated intravascular coagulation. J Trauma 60:S12-S19, 2006.
14. Zhang D, Gong S, Hai J, Wang J, Sheng P, Zou W, Dong Y, Hou L: Coagulation parameters and risk of progressive hemorrhagic injury after traumatic brain injury: a systematic review and meta-analysis. BioMed Res Int 2015:1-10, 2015.
15. Nakae R, Takayama Y, Kuwamoto K, Naoe Y, Sato H, Yokota H: Time course of coagulation and fibrinolytic parameters in patients with traumatic brain injury. J Neurotrauma 33:688-695, 2016.
16. MacLeod JB, Lynn M, McKenney MG, Cohn SM, Murtha M: Early coagulopathy predicts mortality in trauma. J Trauma 55(1):39-44, 2003.
17. Whittaker B, Christiaans S, Altice J, Chen M, Bartolucci A, Morgan C, Kerby J, Pittet J: Early coagulopathy is an independent predictor of mortality in children after severe trauma. Shock 39(5):421-426, 2013.
18. Glassberg E, Nadler R, Gendler S, Abramovich A, Spinella PC, Gerhardt RT, Holcomb JB, Kreiss Y: Freeze-dried plasma at the point of injury: from concept to doctrine. Shock 40(6):444-450, 2013.
19. Alam H, Bice L, Butt M, Cho D, Dubick M, Duggan M, Englehart M, Holcomb J, Morris M, Prince M, et al.: Testing of blood products in a polytrauma model: results of a multi-institutional randomized preclinical trial. J Trauma 67(4):856-864, 2009.
20. Sondeen JL, Coppes VG, Holcomb JB: Blood pressure at which rebleeding occurs after resuscitation in swine with aortic injury. J Trauma 54(5 suppl): S110-S117, 2003.
21. Lee L, Moore E, Hansen K, Silliman C, Chandler J, Banerjee A: It's not your granfather's field plasma. Surgery 153(6):857-860, 2013.
22. Holcomb JB, Jenkins D, Rhee P, Johannigman J, Mahoney P, Mehta S, Cox ED, Gehrke MJ, Beilman GJ, Schreiber M, et al.: Damage control resuscitation: directly addressing the early coagulopathy of trauma. J Trauma 62(2):307-310, 2007.
23. Jenkins D, Stubbs J, Williams S, Berns K, Zielinski M, Strandenes G, Zietlow S: Implementation and execution of civilian remote damage control resuscitation programs. Shock 41(suppl 1):84-89, 2014.
24. Murdock AD, Berseus O, Hervig T, Strandenes G, Lunde TH: Whole blood: the future of traumatic hemorrhagic shock resuscitation. Shock 41(suppl 1):62-69, 2014.
25. Schenk S, Schoenhals G, dee Souza G, Mann M: A high confidence, manually validated human blood plasma protein reference set. BMC Med Genomics 1(41):1-28, 2008.
26. Schmidt PJ: The plasma wars: a history. Transfusion 52(suppl):2-4, 2012.
27. Pennardt A: The time to field freeze dried plasma is now. J Spec Oper Med 10(3):49, 2010.
28. Wallis J, Dzik S: Is fresh frozen plasma overtransfused in the United States? Transfusion 44(11):1674-1675, 2004.
29. Standards for Blood Banks and Transfusion Services, 26th ed. In: Committee on Standards, A., ed., American Association of Blood Banks; 2009.
30. Bux J, Dickhorner D, Scheel E: Quality of freeze-dried (lyophilized) quarantined single-donor plasma. Transfusion 53(12):3203-3209, 2013.
31. Martinaud C, Ausset S, Deshayes AV, Cauet A, Demazeau N, Sailliol A: Use of freeze-dried plasma in French intensive care unit in Afghanistan. J Trauma 71(6):1761-1764, 2011.
32. Spinella P, Frazier E, Pidcoke H, Dietzen D, Pati S, Gorkun O, Aden J, Norris P, Cap A: All plasma products are not created equal: characterizing differences between plasma products. J Trauma Acute Care Surg 78:S18-S25, 2015.
33. Moore HB, Moore EE, Gonzalez E, Wiener G, Chapman MP, Dzieciatkowska M, Sauaia A, Banerjee A, Hansen KC, Silliman C: Plasma is the physiologic buffer of tissue plasminogen activator-mediated fibrinolysis: rationale for plasma-first resuscitation after life-threatening hemorrhage. J Am Coll Surg 220(5):872-879, 2015.
34. Novak D, Bai Y, Cooke R, Marques M, Fontaine M, Gottschall J, Carey P, Scanlan R, Fiebig E, Shulman I, et al.: Making thawed universal donor plasma available for massively bleeding trauma patients: experience from the pragmatic, randomized optimal platelets and plasma ratios (PROPPR) trial. Transfusion 55:1331-1339, 2015.
35. Holcomb JB, Tilley BC, Baraniuk S, Fox EE, Wade CE, Podbielski JM, del Junco DJ, Brasel KJ, Bulger EM, Callcut RA, et al.: Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA 313(5): 471-482, 2015.
36. Peiniger S, Nienaber U, Lefering R, Braun M, Wafaisade A, Wutzler S, Borgmann M, Spinella PC, Maegele M: Trauma Registry of the Deutsche Gesellschaft fur Unfallchirurgie: Balanced massive transfusion ratios in multiple injury patients with traumatic brain injury. Crit Care 15(1):R68, 2011.
37. del Junco DJ, Holcomb JB, Fox EE, Brasel KJ, Phelan HA, Bulger EM, Schreiber MA, Muskat P, Alarcon LH, Cohen MJ, et al.: Resuscitate early with plasma and platelets or balance blood products gradually: findings from the PROMMTT study. J Trauma Acute Care Surg 75(1 suppl 1):S24-S30, 2013.
38. Holcomb JB, Pati S: Optimal trauma resuscitation with plasma as the primary resuscitative fluid: the surgeon's perspective. Hematology Am Soc Hematol Educ Program 2013:656-659, 2013.
39. American College of Surgeons. Quality Improvement Project: Trauma Resuscitation Best Practice Guidelines. Chicago, IL: American College of Surgeons; 2013.
40. Ward GR: Transfusion of plasma. Br Med J 1:301, 1918.
41. Elliott J: A preliminary report of a new method of blood transfusion. South Med Surg 97:7-10, 1936.
42. Stetten D: The blood plasma for Great Britain project. Bull N Y Acad Med 17(1):17-28, 1941.
43. Council on Pharmacy, Chemistry, AMA. Human blood plasma and serum. JAMA 117:934-935, 1941.
44. Robinson G: American Red Cross Blood Donor Service During World War II: Its Organization and Operation. Washington, DC: American National Red Cross; 1946.
45. Alam HB, Rhee P: New developments in fluid resuscitation. Surg Clin North Am 87(1):55-72, 2007.
46. Schreiber MA: The use of normal saline for resuscitation in trauma. J Trauma 70(5 suppl):S13-S14, 2011.
47. Perel P, Roberts I: Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev; 2007;(4):CD000567, 2007.
48. Haut ER, Kalish BT, Cotton BA, Efron DT, Haider AH, Stevens KA, Kieninger AN, Cornwell EE, 3rd, Chang DC: Prehospital intravenous fluid administration is associated with higher mortality in trauma patients: a national trauma data bank analysis. Ann Surg 253(2):371-377, 2011.
49. Alam HB, Rhee P: New trends in fluid resuscitation. Surg Clin North Am 87(1):55-72, 2007.
50. Santry HP, Alam HB: Fluid resuscitation: past, present, and the future. Shock 33(3):229-241, 2010.
51. Rhee P, Burris D, Kaufmann C, Pikoulis M, Austin B, Ling G, Harviel D, Waxman K: Lactated ringer's solution resuscitation causes neutrophil activation after hemorrhagic shock. J Trauma 44(2):313-319, 1998.
52. Hewitt P, Llewelyn C, Mackenzie J, Will R: Creutzfeldt-Jakob disease and blood transfusion: results of the UK transfusion medicine epidemiological review study. Vox Sang 91:221-230, 2006.
53. Alam HB, Stanton K, Koustova E, Burris D, Rich N, Rhee P: Effect of different resuscitation strategies on neutrophil activation in a swine model of hemorrhagic shock. Resuscitation 60(1):91-99, 2004.
54. Chen H, Koustova E, Shults C, Sailhamer EA, Alam HB: Differential effect of resuscitation on toll-like receptors in a model of hemorrhagic shock without a septic challenge. Resuscitation 74(3):526-537, 2007.
55. Borgman MA, Spinella PC, Perkins JG, Grathwohl KW, Repine T, Beekley AC, Sebesta J, Jenkins D, Wade CE, Holcomb JB: The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma 63(4):805-813, 2007.
56. Duchesne JC, Hunt JP, Wahl G, Marr AB, Wang YZ, Weintraub SE, Wright MJ, McSwain NE Jr: Review of current blood transfusions strategies in a mature level I trauma center: were we wrong for the last 60 years? J Trauma 65(2): 272-276, 2008.
57. Spinella PC, Holcomb JB: Resuscitation and transfusion principles for traumatic hemorrhagic shock. Blood Rev 23(6):231-240, 2009.
58. Spinella PC, Perkins JG, Grathwohl KW, Beekley AC, Niles SE, McLaughlin DF, Wade CE, Holcomb JB: Effect of plasma and red blood cell transfusions on survival in patients with combat related traumatic injuries. J Trauma 64(2 suppl):S69-S77, 2008.
59. Brakenridge S, Phelan H, Henley S, Golden R, Kashner T, Eastman A, Sperry J, Harbrecht B, Moore E, Cuschieri J, et al.: Early blood product and crystalloid volume resuscitation: risk association with multiple organ dysfunction after severe blunt traumatic injury. J Trauma 71(2):299-305, 2011.
60. Zink KA, Sambasivan CN, Holcomb JB, Chisholm G, Schreiber MA: A high ratio of plasma and platelets to packed red blood cells in the first 6 hours of massive transfusion improves outcomes in a large multicenter study. Am J Surg 197(5):565-570, 2009.
61. Scalea TM, Bochicchio KM, Lumpkins K, Hess JR, Dutton R, Pyle A, Bochicchio GV: Early aggressive use of fresh frozen plasma does not improve outcome in critically injured trauma patients. Ann Surg 248(4):578-584, 2008.
62. Kim BD, Zielinski MD, Jenkins DH, Schiller HJ, Berns KS, Zietlow SP: The effects of prehospital plasma on patients with injury: a prehospital plasma resuscitation. J Trauma Acute Care Surg 73(2 suppl 1):S49-S53, 2012.
63. Pati S, Matijevic N, Doursout MF, Ko T, Cao Y, Deng X, Kozar RA, Hartwell E, Conyers J, Holcomb JB: Protective effects of fresh frozen plasma on vascular endothelial permeability, coagulation, and resuscitation after hemorrhagic shock are time dependent and diminish between days 0 and 5 after thaw. J Trauma 69(suppl 1):S55-S63, 2010.
64. Matijevic N, Wang Y, Cotton B, Hartwell E, Barbeau J, Wade C, Holcomb J: Better hemostatic profiles of never-frozen liquid plasma compared with thawed fresh frozen plasma. J Trauma Acute Care Surg 74:84-91, 2013.
65. Pandey S, Vyas GN: Adverse effects of plasma transfusion. Transfusion 52(suppl 1):65S-79S, 2012.
66. Kakaiya R, Morse E, Panek S: Labile coagulation factors in thawed fresh frozen plasma prepared by two methods. Vox Sang 46(1):44-46, 1984.
67. O'Neill E, Rowley J, Hansson-Wicher M, McCarter S, Ragno G, Valeri C: Effect of 24-hour whole-blood storage on plasma clotting factors. Transfusion 39(5):488-491, 2002.
68. Downes K, Wilson E, Yomtovian R, Sarode R: Serial measurement of clotting factors in thawed plasma stored for 5 days. Transfusion 41(4):570, 2001.
69. Sidhu R, Le T, Brimhall B, Thompson H: Study of coagulation factor activities in apheresed thawed fresh frozen plasma at 1-6 degrees C for five days. J Clin Apher 21(4):224-226, 2006.
70. Rhee P, Koustova E, Alam HB: Searching for the optimal resuscitation method: recommendations for the initial fluid resuscitation of combat casualties. J Trauma 54(5 suppl):S52-S62, 2003.
71. Sailliol A, Martinaud C, Cap AP, Civadier C, Clavier B, Deshayes AV, Mendes AC, Pouget T, Demazeau N, Chueca M, et al.: The evolving role of lyophilized plasma in remote damage control resuscitation in the French armed forces health service. Transfusion 53(suppl 1):65S-71S, 2013.
72. Vamvakas E, Blajchman M: Blood still kills: six strategies to further reduce allogeneic blood transfusion-related mortality. Transfus Med Rev 24(2): 77-124, 2010.
73. Shuja F, Finkelstein RA, Fukudome E, Duggan M, Kheirbek T, Hamwi K, Fischer TH, Fikry K, deMoya M, Velmahos GC, et al.: Development and testing of low-volume hyperoncotic, hyperosmotic spray-dried plasma for the treatment of trauma-associated coagulopathy. J Trauma 70(3):664-671, 2011.
74. Alam HB, Hamwi KB, Duggan M, Fikry K, Lu J, Fukudome EY, Chong W, Bramos A, Kim K, Velmahos G: Hemostatic and pharmacologic resuscitation: results of a long-term survival study in a swine polytrauma model. J Trauma 70(3):636-645, 2011.
75. Martinaud C, Civadier C, Ausset S, Verret C, Deshayes AV, Sailliol A: In vitro hemostatic properties of French lyophilized plasma. Anesthesiology 117(2): 339-346, 2012.
76. Pati S, Matijevic N, Doursout MF, Ko T, Cao Y, Deng X, Kozar RA, Hartwell E, Conyers J, Holcomb JB: Protective effects of fresh frozen plasma on vascular endothelial permeability, coagulation, and resuscitation after hemorrhagic shock are time dependent and diminish between days 0 and 5 after thaw. J Trauma 69(suppl 1):S55-S63, 2010.
77. Matijevic N, Kostousov V, Wang YW, Wade CE, Wang W, Letourneau P, Hartwell E, Kozar R, Ko T, Holcomb JB: Multiple levels of degradation diminish hemostatic potential of thawed plasma. J Trauma 70(1):71-79, 2011.
78. American Association of Blood Banks. The 2009 national blood collection and utilization survey report. Available at: http://www.aabb.org/programs/biovigilance/nbcus/Documents/09-nbcus-report.pdf. Accessed July 12, 2015.
79. Starkey K, Keene D, Morrison Mrcs J, Doughty H, Midwinter M, Woolley T, Jansen Ficm J: Impact of high ratios of plasma-to-red-cell-concentrate on the incidence of acute respiratory distress syndrome in UK transfused combat casualties. Shock 40:15-20, 2013.
80. Zou S, Musavi F, Notari E, Stramer S, Dodd R: Prevalence, incidence, and residual risk of major blood-borne infections among apheresis collections to the American Red Cross Blood Services, 2004 through 2008. Transfusion 50:1487-1494, 2010.
81. Zou S, Stramer S, Notari E, Kuhns M, Krysztof D, Musavi F, Fang C, Dodd R: Current incidence and residual risk of hepatitis B infection among blood donors in the United States. Transfusion 49:1609-1620, 2009.
82. Goldman M, Webert K, Arnold D, Freedman J, Hannon J, Blajchman M: TRALI Consensus Panel: Proceedings of a consensus conference: towards an understanding of TRALI. Transfus Med Rev 19:2-31, 2005.
83. Toy P, Gajic O, Bacchetti P, Looney MR, Gropper MA, Hubmayr R, Lowell CA, Norris PJ, Murphy EL, Weiskopf RB, et al.: Transfusion-related acute lung injury: incidence and risk factors. Blood 119(7):1757-1767, 2012.
84. Toy P, Popovsky MA, Abraham E, Ambruso DR, Holness LG, Kopko PM, McFarland JG, Nathens AB, Silliman CC, Stroncek D, National Heart, Lung and Blood Institute Working Group on TRALI. Transfusion-related acute lung injury: definition and review. Crit Care Med 33(4):721-726, 2005.
85. Holness L, Knippen M, Simmons L, Lachenbruch P: Fatalaties caused by TRALI. Transfus Med Rev 18:184-188, 2004.
86. Chapman C, Stainsby D, Jones H, Love E, Massey E, Win N, Navarrete C, Lucas G, Soni N, Morgan C, et al.: Ten years of hemovigilance reports of transfusion-related lung injury in the United Kingdom and the impact of preferential use of male donor plasma. Transfusion 49:440-452, 2009.
87. Kleinman S, Caulfield T, Chan P, Davenport R, McFarland J, McPhedran S, Meade M, Morrison D, Pinsent T, Robillard P, et al.: Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion 44(12):1774-1789, 2004.
88. Sheppard C, Logdberg L, Zimring J, Hillyer C: Transfusion-related acute lung injury. Hematol Oncol Clin North Am 21:163-176, 2007.
89. Silliman C, McLaughlin N: Transfusion-related acute lung injury. Blood Rev 20:139-159, 2006.
90. Sachs U, Hattar K, Weissmann N, Bohle R, Weiss T, Sibelius U, Bux J: Antibody-induced neutrophil activation as a trigger for transfusion-related acute lung injury in an ex vivo rat lung model. Blood 107:1217-1219, 2006.
91. Popovsky M, Haley N: Further characterization of transfusion-related acute lung injury: demographics, clinical and laboratory features, and morbidity. Immunohematology 16:157-159, 2000.
92. Seeger W, Schneider U, Kreusler B, von Witzleben E, Walmrath D, Grimminger F, Neppert J: Reproduction of transfusion-related acute lung injury in an ex vivo lung model. Blood 76:1438-1444, 1990.
93. Takahashi D, Fujihara M, Azuma H, Miyazaki T, Uchimura D, Wakamoto S, Sato S, kato T, Ikeda H: Stimulation of human neutrophils with sera containing HLA Class I alloantibody causes preferential degranulation of azurophilic granules and secretory vesicles. Vox Sang 98:560-566, 2010.
94. Shaz B, Stowell S, Hilyer C: Transfusion-related acute lung injury: from bedside to bench and back. Blood 117:1463-1471, 2011.
95. Middelburg R, van Stein D, Briet E, van der Bom J: The role of donor antibodies in the pathogenesis of transfusion-related acute lung injury: a systematic review. Transfusion 48:2167-2176, 2008.
96. Triulzi D, Kleinman S, Kakaiya R, Busch M, Norris P, Steele W, Glynn S, Hillyer C, Carey P, Gottschall J, et al.: The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion related acute lung injury (TRALI) risk reduction strategy. Transfusion 49(9):1825-1835, 2009.
97. Eder A, Herron RJ, Strupp A, Dy B, White J, Notari E, Dodd R, Benjamin R: Effective reduction of transfusion-related acute lung injury risk with malepredominant plasma strategy in the American Red Cross (2006-2008). Transfusion 50:1732-1742, 2010.
98. Funk M, Guenay S, Lohmann A, Henseler O, Heiden M, Hanschmann K, Keller-Stanislawski B: Benefit of transfusion-related acute lung injury riskminimization measures - German haemovigilance data (2006-2010). Vox Sang 102(4):317-323, 2011.
99. Lin Y, Saw C, Hannach B, Goldman M: Transfusion-related acute lung injury prevention measures and their impact at Canadian blood services. Transfusion 52(3):567-574, 2011.
100. Skeate R, Eastlund T: Distinguishing between transfusion related acute lung injury and transfusion related associated circulatory overload. Curr Opin Hematol 14(6):682-687, 2007.
101. Popovsky M: Transfusion and the lung: circulatory overload and acute lung injury. Vox Sang 87:62-65, 2004.
102. Narick C, Triulzi D, Yazer M: Transfusion-association circulatory overload after plasma transfusion. Transfusion 52:160-165, 2012.
103. Li G, Rachmale S, Kojicic M, Shahjehan K, Malinchoc M, Kor D, Gajic O: Incidence and transfusion risk factors for transfusion-associated circulatory overlaod among medical intensive care unit patients. Transfusion 51:338-343, 2011.
104. Pomper G: Febrile, allergic and nonimmune transfusion reactions. In: Simon T, Snyder E, Solheim B, Stowell C, Strauss R, Petrides M, editors. Rossi's Principles of Transfusion Medicine4th ed, Hoboken, NJ: Wiley-Blackwell; 2009, p. 837-838.
105. Fatalaties Reported to the FDA Following Blood Collection and Transfusion: Annual Summary for Fiscal Year. 2010. Available at: http://www.fda.gov/cber/blood/safetyavailability/reportaproblem/transfusiondonationfatalities/UCM113649.html. Accessed July 12, 2015.
106. Domen R, Hoeltge G: Allergic transfusion reactions: an evaluation of 273 consecutive reactions. Arch Pathol Lab Med 127:316-320, 2003.
107. Kennedy L, Case L, Hurd D, Cruz J, Popmer G: A prospective, randomized, double-blind controlled trial of acetaminophen and diphenhydramine pretransfusion medications versus placebo for the prevention of transfusion reactions. Transfusion 48:2285-2291, 2008.
108. Wang S, Lara PJ, Lee-Ow A, Reed J, Wang L, Palmer P, Tuscano J, Richman C, Beckett L, Wun T: Acetaminophen and diphenhydramine as premedications for platelet transfusions: a prospective randomized double-blind placebocontrolled trial. Am J Hematol 70:191-194, 2002.
109. Public Health Agency of Canada. Transfusion transmitted injuries surveillance system program report: 2001-2003. Available at: http://www.phac-aspc.gc.ca/hcai-iamss/tti-it/pr-re0304/pdf/ttiss-report0203-e.pdf. Accessed August 15, 2015.
110. Keller-Stanislawski B, Lohmann A, Gunay S, Heiden M, Funk M: The German haemovigilance system - reports of serious adverse transfusion reactions between 1997 and 2007. Transfus Med 19:340-349, 2009.
111. Nielsen H, Reimert C, Pedersen A, Dybkjoer E, Brunner N, Alsbjorn B, Skov P: Leukocyte-derived bioactive substances in fresh frozen plasma. Br J Anaesth 78:548-552, 1997.
112. Watts S, Nordmann G, Brohi K, Midwinter M, Woolley T, Gwyther R, Wilson C, Poon H, P., Kirkman E: Evaluation of prehospital blood products to attenuate acute coagulopathy of trauma in a model of severe injury and shock in anesthetized pigs. Shock 44(suppl 1):S138-S148, 2015.
113. Wafaisade A, Lefering R, Tjardes T, Wutzler S, Simanski C, Paffrath T, Fischer P, Bouillon B, Maegele M, TraumaRegistry of DGU. Acute coagulopathy in isolated blunt traumatic brain injury. Neurocrit Care 12(2):211-219, 2010.
114. Vandendries E, Furie B, Furie B: Role of P-selectin and PSGL-1 in coagulation and thrombosis. Thromb Haemost 92:459-466, 2004.
115. Peng Z, Pati S, Potter D, Brown R, Holcomb JB, Grill R, Wataha K, Park PW, Xue H, Kozar RA: Fresh frozen plasma lessens pulmonary endothelial inflammation and hyperpermeability after hemorrhagic shock and is associated with loss of syndecan 1. Shock 40(3):195-202, 2013.
116. Wataha K, Menge T, Deng X, Shah A, Bode A, Holcomb JB, Potter D, Kozar R, Spinella PC, Pati S: Spray-dried plasma and fresh frozen plasma modulate permeability and inflammation in vitro in vascular endothelial cells. Transfusion 53(suppl 1):80S-90S, 2013.
117. Kozar R, Peng Z, Zhang R, Holcomb J, Pati S, Park P, Ko T, Parades A: Plasma restoration of endothelial glycocalyx in a rodent model of hemorrhagic shock. Anesth Analg 112(6):1289-1295, 2011.
118. Torres LN, Sondeen JL, Ji L, Dubick MA, Filho IT: Evaluation of resuscitation fluids on endothelial glycocalyx, venular blood flow, and coagulation function after hemorrhagic shock in rats. J Trauma Acute Care Surg 75(5):759-766, 2013.
119. Potter DR, Baimukanova G, Keating SM, Deng X, Chu JA, Gibb SL, Peng Z, Muench MO, Fomin ME, Spinella PC, et al.: Fresh frozen plasma and spraydried plasma mitigate pulmonary vascular permeability and inflammation in hemorrhagic shock. J Trauma Acute Care Surg 78(6 suppl 1):S7-S17, 2015.
120. Deb S, Sun L, Martin B, Talens E, Burris D, Kaufmann C, Rich N, Rhee P: Lactated ringer's solution and hetastarch but not plasma resuscitation after rat hemorrhagic shock is associated with immediate lung apoptosis by the upregulation of the Bax protein. J Trauma 49(1):47-53, 2000.
121. Murthi SB, Stansbury LG, Hess JR: Blood and coagulation support in trauma. Blood Rev 23(4):149-155, 2009.
122. Hess JR: Blood and coagulation support in trauma care. Hematology Am Soc Hematol Educ Program; 2007;187-191, 2007.
123. Nillson L, Hedner U, Nillson I, Robertson B: Shelf-life of bank blood and stored plasma with special reference to coagulation factors. Transfusion 23:377-381, 1983.
124. Carpenter J, Manning M, Randolph T: Long-term Storage of Proteins. Curr Protoc Protein Sci UNIT 4.6 Supplement:1-6, 2002.
125. Spoerke N, Zink K, Cho SD, Differding J, Muller P, Karahan A, Sondeen J, Holcomb JB, Schreiber M: Lyophilized plasma for resuscitation in a swine model of severe injury. Arch Surg 144(9):829-834, 2009.
126. Inaba K: Freeze-dried plasma. J Trauma 70(5 suppl):S57-S58, 2011.
127. Schoenfeld H, Pruss A, Keller M, Schuster M, Meinck K, Neuner B, von Heymann C: Lyophylised plasma: evaluation of clotting factor activity over 6 days after reconstitution for transfusion. J Clin Pathol 63:726-730, 2010.
128. Van PY, Hamilton GJ, Kremenevskiy IV, Sambasivan C, Spoerke NJ, Differding JA, Watters JM, Schreiber MA: Lyophilized plasma reconstituted with ascorbic acid suppresses inflammation and oxidative DNA damage. J Trauma 71(1):20-24, 2011.
129. Hamilton GJ, Van PY, Differding JA, Kremenevskiy IV, Spoerke NJ, Sambasivan C, Watters JM, Schreiber MA: Lyophilized plasma with ascorbic acid decreases inflammation in hemorrhagic shock. J Trauma 71(2):292-297, 2011.
130. Lee TH, Watson K, Fabricant L, Barton J, Differding J, Kremenevskiy I, Sands C, Wiles C, Watters JM, Schreiber MA: Hyperosmolar reconstituted lyophilized plasma is an effective low-volume hemostatic resuscitation fluid for trauma. J Trauma Acute Care Surg 75(3):369-375, 2013.
131. McCully SP, Martin DT, Cook MR, Gordon NT, McCully BH, Lee TH, Dean RK, Rick EA, Moren AM, Fair KA, et al.: Effect of ascorbic acid concentrations on hemodynamics and inflammation following lyophilized plasma transfusion. J Trauma Acute Care Surg 79(1):30-38, 2015.
132. Rahbar E, Baer L, Cotton B, Holcomb J, Wade C: Plasma colloid osmotic pressure is an early indicator of injury and hemorrhagic shock. Shock 41(3):181-187, 2014.
133. Chapman M, Moore E, Chin T, Ghasabyan A, Chandler J, Stringham J, Gonzalez E, Moore H, Banerjee A, Silliman C, et al.: COMBAT: initial experience with a randomized clinical trial of plasma-based resuscitation in the field for traumatic hemorrhagic shock. Shock 44(suppl 1):S63-S70, 2015.
134. Reynolds P, Michael M, Cochran E, Wegelin J, Spiess B: Prehospital use of plasma in traumatic hemorrhage (the PUPTH trial): study protocol for a randomised controlled trial. Trials 16:321, 2015.
135. Branco B, Inaba K, Ives C, Okoye O, Shulman I, David J, Schochl H, Rhee P, Demetriades D: Thromboelastogram evaluation of the impact of hypercoagulability in trauma patients. Shock 41(3):200-207, 2014.
136. Mella J, Chiswick E, King E, Remick D: Location, location, location: cytokine concentrations are dependent on blood sampling site. Shock 42(4): 337-342, 2014.